Partner Headlines - EXEL

  1. Benzinga's Top #PreMarket Gainers

    Benzinga
  2. 5 Stocks You Should Be Watching Today

    Benzinga
  3. The Best-Performing Non-S&P Stocks of 2015

    GuruFocus
  4. Top-Performing Non-S&P 500 Stocks of the Year

    GuruFocus
  5. Top Stocks 2015: Biotechs, Wayfair, Netflix, Amazon

    IBD
  6. Exelixis Announces Presentation of Positive Overall Survival ...

    Benzinga
  7. Morning Market Gainers

    Benzinga
  8. Benzinga's Top #PreMarket Gainers

    Benzinga
  9. Exelixis Announces Positive Overall Survival Results from coBRIM ...

    Benzinga
  10. Morning Market Losers

    Benzinga
  11. Benzinga's Top #PreMarket Losers

    Benzinga
  12. Jim Cramer Shares His Thoughts On Home Depot, Bristol-Myers Squibb, ...

    Benzinga
  13. Morning Market Gainers

    Benzinga
  14. Benzinga's Top #PreMarket Gainers

    Benzinga
  15. Benzinga's Top #PreMarket Gainers

    Benzinga
  16. Exelixis Prices 25M Share Offering @$5.40/Share

    Benzinga
  17. Benzinga's Top #PreMarket Losers

    Benzinga
  18. Ethical-Drug Firms Horizon Pharma, Bristol-Myers Rally

    IBD
  19. Bristol-Myers: kidney drug win

    IBD
  20. Market Update: Monday's Mid-Day Movers; Greece Opens Banks; Gold ...

    Benzinga
  21. Bristol-Myers, Exelixis Drugs Score Vs. Kidney Cancer

    IBD
  22. Mid-Morning Market Update: Markets Mostly Flat; Morgan Stanley ...

    Benzinga
  23. Benzinga's Top #PreMarket Gainers

    Benzinga
  24. Exelixis Announces Start of Phase 1 Trial of Cabozantinib in ...

    Benzinga
  25. Benzinga's Top #PreMarket Losers

    Benzinga
  26. Watch These 10 Stocks Over The Weekend

    Benzinga
  27. Morning Market Gainers

    Benzinga
  28. Benzinga's Top #PreMarket Gainers

    Benzinga
  29. Morning Market Gainers

    Benzinga
  30. Benzinga's Top #PreMarket Gainers

    Benzinga
  31. Exelixis Data Release Upcoming; Options Activity Spiking

    Benzinga
  32. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  33. 5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic ...

    GuruFocus
  34. Mid-Day Market Update: ON Semiconductor Surges On $1 Billion ...

    Benzinga
  35. Mid-Morning Market Update: Markets Open Lower; Weatherford To ...

    Benzinga
  36. Morning Market Losers

    Benzinga
  37. Events for the Week of Nov. 17-21, 2014

    Benzinga
  38. Morning Market Movers

    Benzinga
  39. 5-year lows: National Presto Industries, Ennis Inc, Landauer ...

    GuruFocus
  40. Stocks Hitting 52-Week Lows

    Benzinga
  41. Equities, Commodities & Bonds Finish Lower On First Trading Day ...

    Benzinga
  42. Midday Losers From Tuesday, September 2

    Benzinga
  43. Exelixis Shares Slide On Trial Results; Norwegian Cruise Line ...

    Benzinga
  44. Markets Mixed; Conn's Profit Misses Estimates

    Benzinga
  45. Stocks Hitting 52-Week Lows

    Benzinga
  46. Morning Market Losers

    Benzinga
  47. Benzinga's Top Downgrades

    Benzinga
  48. Stifel Nicolaus Downgrades Exelixis To Hold

    Benzinga
  49. Stocks To Watch For September 2, 2014

    Benzinga
  50. Exelixis Announces Results From COMET-1 Phase 3 Pivotal Trial ...

    Benzinga
  51. Mid-Afternoon Market Update: Harmonic Drops On Weak Forecast; ...

    Benzinga
  52. Harmonic Drops On Weak Forecast; URS Shares Surge

    Benzinga
  53. Mid-Morning Market Update: Markets Open Higher; Citigroup Profit ...

    Benzinga
  54. Morning Market Movers

    Benzinga
  55. Exelixis Shares Move 12% On Phase 3 Data

    Benzinga
  56. Benzinga's Top #PreMarket Gainers

    Benzinga
  57. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  58. Benzinga's Top #PreMarket Gainers

    Benzinga
  59. Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian ...

    GuruFocus
  60. Market Wrap For March 26: Markets Close Near Session Lows In ...

    Benzinga
  61. Mid-Afternoon Market Update: Markets Turn Red as Dish Network ...

    Benzinga
  62. Mid-Day Market Update: Five Below Jumps On Upbeat Results; Exelixis ...

    Benzinga
  63. Mid-Morning Market Update: Markets Open Higher; Francesca's Issues ...

    Benzinga
  64. Stocks Hitting 52-Week Lows

    Benzinga
  65. Morning Market Losers

    Benzinga
  66. Benzinga's Top #PreMarket Losers

    Benzinga
  67. Morning Market Movers

    Benzinga
  68. US Stock Futures Rise Ahead Of Housing Data

    Benzinga
  69. Exelixis Prices 10M Share Offering at $8 per Share

    Benzinga
  70. Oversold ETFs Looking Attractive (IHE, CSD, PSCE)

    Benzinga
  71. Exelixis Announces Promising Phase 1b Data for Cobimetinib in ...

    Benzinga
  72. US Stock Futures Rise Ahead Of Jobless Claims, GDP Data

    Benzinga
  73. Exelixis Announces Full Patient Enrollment for COMET-1 Phase ...

    Benzinga
  74. US Stock Futures Up After Upbeat China Data

    Benzinga
  75. Exelixis Initiates Phase 3 Clinical Trial of Cabozantinib

    Benzinga
  76. Exelixis Receives EMA Acceptance of Marketing Authorization App ...

    Benzinga
  77. Exelixis Inc. Reports Operating Results (10-Q)

    GuruFocus
  78. Exel Presents Interim Data for Cabozantinib 40 mg Dose Cohort ...

    Benzinga
  79. First Solar, Sears Holdings Among Stocks Down on Above-average ...

    FoxBusiness
  80. Exelixis Says FDA Says NDA Has Been Removed from November Agenda

    Benzinga
  81. UPDATE: Piper Jaffray Reduces PT to $4.50 on Exelixis on Equity ...

    Benzinga
  82. Social Media Outlook for Thursday August 9 (EAT, NOV, NWSA, FSYS)

    Benzinga
  83. Exelixis, Universal Display Corporation Among Stocks Up on High ...

    FoxBusiness
  84. FDA's Oncologic Drugs Advisory Committee to Review Exelixis New ...

    Benzinga
  85. Exelixis (EXEL) Loses 8.8% As Company Sells Stock, Debt

    MarketIntelligenceCenter
  86. Health Care Sector Wrap

    FoxBusiness
  87. HCA Holdings, American Capital Mortgage Investment Crp Among ...

    FoxBusiness
  88. Interpublic Group, Exelixis Gapping Down Monday

    FoxBusiness
  89. UPDATE: Exelixis Announces Proposed Convertible Debt Offering ...

    Benzinga
  90. Exelixis Proposed Offering 20M Shares

    Benzinga
  91. Exelixis Inc. Reports Operating Results (10-Q)

    GuruFocus
  92. Social Media Outlook for Monday July 30 (SHAW, BBY, EXEL, VHC)

    Benzinga
  93. Benzinga's Top Pre-Market Gainers

    Benzinga
  94. FDA Grants Priority Review for Cabozantinib in Medullary Thyroid ...

    Benzinga
  95. Exelixis Announces Initiation of Cabozantinib Investigator-Sponsored ...

    Benzinga
  96. Jefferies Reiterates Hold Rating, $6 PT for Exelixis

    Benzinga
  97. Cabozantinib Demonstrates Durable Effects in Bone and Soft Tissue ...

    Benzinga
  98. Cabozantinib Meets Primary Endpoint of Progression Free Survival ...

    Benzinga
  99. Cabozantinib Demonstrates Evidence of Anti-Tumor Effects in Heavily ...

    Benzinga
  100. Exelixis Completes Submission of New Drug Application for Cabozantinib ...

    Benzinga
Trading Center